Table 1 Clinical and laboratory features of patients with HFRS stratified by five stages or two disease phases (acute and convalescent).

From: HTNV infection of CD8+ T cells is associated with disease progression in HFRS patients

 

Acute phase

Convalescent phase

Febrile

Hypotensive

Oliguric

Diuretic

Convalescent

(n = 45)

(n = 24)

(n = 75)

(n = 108)

(n = 28)

Age (years)

48.0 [27.8, 55.0]

41.0 [34.5, 55.0]

45.0 [29.0, 54.5]

46.0 [29.0, 54.5]

49.0 [29.8, 56.0]

Sex

 Male

28 (62.2%)

17 (70.8%)

56 (74.7%)

80 (74.1%)

18 (64.3%)

 Female

17 (37.8%)

7 (29.2%)

19 (25.3%)

28 (25.9%)

10 (35.7%)

White blood cell count, ×109/L

12.6 [8.1, 16.3]

14.1 [8.9, 33.0]

10.9 [7.9, 16.0]

8.1 [6.4, 10.1]

7.1 [6.2, 9.0]

Platelet count, ×109/L

65.0 [40.8, 87.5]

43.0 [25.0, 85.2]

84.0 [53.0, 137.0]

196.5 [107.5, 254.8]

205.0 [144.5, 282.0]

Hemoglobin, g/L

122.0 [111.8, 133.5]

123.0 [93.5, 134.2]

114.0 [98.0, 125.0]

111.5 [100.0, 129.0]

122.0 [103.5, 134.0]

Lymphocyte count, ×109/L

3.6 [2.4, 5.1]

2.5 [1.8, 9.1]

2.7 [1.5, 4.4]

1.8 [1.3, 2.3]

1.7 [1.4, 2.4]

Neutrophil count, ×109/L

6.7 [4.4, 8.8]

5.5 [4.2, 12.8]

7.3 [4.4, 9.4]

4.8 [3.7, 6.1]

4.1 [3.4, 5.2]

Alanine transaminase (ALT), U/L

53.0 [37.5, 75.0]

68.5 [46.8, 105.8]

61.0 [44.0, 92.0]

55.5 [34.0, 81.5]

48.0 [36.5, 73.2]

Aspartate transaminase (AST), U/L

55.0 [46.0, 76.0]

90.5 [48.2, 164.8]

57.0 [42.0, 120.0]

43.0 [31.0, 61.0]

33.5 [27.2, 49.5]

AST/ALT

1.1 [0.9, 1.5]

1.5 [1.0, 1.9]

1.0 [0.8, 1.4]

0.8 [0.6, 1.0]

0.7 [0.6, 1.0]

Creatinine, μmol/L

96.0 [72.1, 196.2]

146.9 [105.2, 254.8]

260.2 [167.1, 356.5]

186.3 [104.2, 301.9]

98.4 [66.2, 202.6]

Albumin, g/L

28.4 [27.1, 31.2]

31.6 [27.2, 33.7]

31.1 [29.5, 34.4]

36.0 [33.2, 40.7]

36.2 [33.4, 38.7]

Uric acid, μmol/L

302.8 [216.6, 446.0]

251.6 [141.9, 350.9]

217.9 [121.9, 415.6]

431.9 [296.0, 533.8]

390.0 [274.4, 454.4]

Blood urea nitrogen, mmol/L

9.0 [5.2, 13.4]

9.5 [7.1, 15.6]

12.1 [8.6, 16.3]

13.0 [7.7, 17.9]

6.2 [5.1, 14.6]

Glomerular filtration rate, mL/min

66.7 [35.2, 109.9]

38.4 [20.8, 67.0]

25.6 [15.8, 35.4]

36.3 [19.2, 68.4]

73.6 [22.8, 97.5]

Prothrombin time, s

10.2 [9.9, 10.7]

11.1 [10.6, 12.2]

10.6 [10.1, 11.8]

11.4 [10.7, 12.1]

10.6 [10.5, 12.1]

Potassium, mmol/L

3.4 [3.2, 3.8]

3.7 [3.4, 3.9]

3.6 [3.3, 4.0]

3.6 [3.1, 3.9]

3.8 [3.2, 4.1]

Sodium, mmol/L

137.6 [133.1, 141.8]

135.1 [132.3, 138.2]

135.5 [133.6, 139.3]

139.6 [136.6, 143.4]

141.0 [138.7, 142.9]

  1. According to clinical practice, the acute phase should cover febrile, hypotensive, and oliguric stages and the convalescent phase diuretic and convalescent stages. Data are presented as the median (interquartile range, IQR) or n (%).
  2. HFRS hemorrhagic fever with renal syndrome.